Back to search

Recombinant Toxins for Cancer Treatment

Data up to Jan 2025

Published1991
Citations308
References87

Total Citations Per Year

Abstract

References (87)

Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes

1986 • 6,284 citations

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

1988 • 1,698 citations

Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli.

1988 • 1,536 citations

Single-Chain Antigen-Binding Proteins

1988 • 1,450 citations

Assembly of a Functional Immunoglobulin F v Fragment in Escherichia coli

1988 • 973 citations

Diphtheria Toxin

1977 • 780 citations

One molecule of diphtheria toxin fragment a introduced into a cell can kill the cell

1978 • 744 citations

B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes.

1983 • 517 citations

Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Angstrom resolution.

1986 • 517 citations

Functional domains of pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli

1987 • 449 citations

Epidermal-Growth-Factor-Dependent Transformation by a Human EGF Receptor Proto-Oncogene

1987 • 448 citations

A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin

1989 • 420 citations

Human squamous cell lung cancers express increased epidermal growth factor receptors.

1984 • 371 citations

Redesigning Nature's Poisons to Create Anti-Tumor Reagents

1987 • 329 citations

Phase I immunotoxin trial in patients with B-cell lymphoma.

1991 • 289 citations

Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cells

1981 • 253 citations

Diphtheria toxin receptor binding domain substitution with interleukin-2: genetic construction and properties of a diphtheria toxin-related interleukin-2 fusion protein

1987 • 236 citations

Processing of Pseudomonas exotoxin by a cellular protease results in the generation of a 37,000-Da toxin fragment that is translocated to the cytosol

1990 • 233 citations

Immunotoxins

1986 • 230 citations

B3(Fv)-PE38KDEL, a single-chain immunotoxin that causes complete regression of a human carcinoma in mice.

1991 • 219 citations

Receptor-mediated endocytosis of epidermal growth factor by rat hepatocytes: receptor pathway.

1986 • 217 citations

Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin.

1987 • 212 citations

Functional Analysis of Domains II, Ib, and III of Pseudomonas exotoxin

1989 • 193 citations

Definition by monoclonal antibodies of a repertoire of epitopes on carcinoembryonic antigen differentially expressed in human colon carcinomas versus normal adult tissues.

1985 • 177 citations

Receptor-mediated internalization of pseudomonas toxin by mouse fibroblasts

1980 • 176 citations

Mutations in Diphtheria Toxin Separate Binding from Entry and Amplify Immunotoxin Selectivity

1987 • 173 citations

Targeted Toxin Therapy for the Treatment of Cancer

1989 • 158 citations

A rapid method of cloning functional variable-region antibody genes in Escherichia coli as single-chain immunotoxins.

1990 • 156 citations

Activity of immunotoxins constructed with modified Pseudomonas exotoxin A lacking the cell recognition domain.

1988 • 147 citations

Antigens associated with a human lung adenocarcinoma defined by monoclonal antibodies.

1984 • 142 citations

Characterization of monoclonal antibodies B1 and B3 that react with mucinous adenocarcinomas.

1991 • 140 citations

Cytotoxic activity of an interleukin 2-Pseudomonas exotoxin chimeric protein produced in Escherichia coli.

1988 • 133 citations

Pseudomonas exotoxin: chimeric toxins

1989 • 129 citations

Phase I Study of an Anti-Breast Cancer Immunotoxin by Continuous Infusion: Report of a Targeted Toxic Effect Not Predicted by Animal Studies

1989 • 124 citations

Clinical evaluation of intraperitoneal Pseudomonas exotoxin immunoconjugate OVB3-PE in patients with ovarian cancer.

1991 • 124 citations

Phase I evaluation of an anti-breast carcinoma monoclonal antibody 260F9-recombinant ricin A chain immunoconjugate.

1989 • 122 citations

In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins.

1982 • 122 citations

How protein toxins enter and kill cells

1988 • 122 citations

Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy.

1988 • 116 citations

TRANSMEMBRANE TRANSPORT OF DIPHTHERIA TOXIN, RELATED TOXINS, AND COLICINS

1986 • 115 citations

Ricin A-chain containing immunotoxins directed against different epitopes on the CD2 molecule differ in their ability to kill normal and malignant T cells.

1988 • 95 citations

Blockade of the galactose‐binding sites of ricin by its linkage to antibody

1984 • 93 citations

Pseudomonas exotoxin-anti-TAC. Cell-specific immunotoxin active against cells expressing the human T cell growth factor receptor.

1984 • 92 citations

Expression of soluble and fully functional ricin A chain in Escherichia coli is temperature-sensitive.

1988 • 92 citations

Tissue distribution of breast cancer-associated antigens defined by monoclonal antibodies.

1985 • 88 citations

Phase I study of monoclonal antibody-ricin A chain immunotoxin XomaZyme-791 in patients with metastatic colon cancer.

1989 • 88 citations

Autologous bone marrow transplantation in high-risk remission T-lineage acute lymphoblastic leukemia using immunotoxins plus 4- hydroperoxycyclophosphamide for marrow purging

1990 • 88 citations

Mutational analysis of domain I of Pseudomonas exotoxin. Mutations in domain I of Pseudomonas exotoxin which reduce cell binding and animal toxicity.

1988 • 87 citations

The galactose-binding sites of the cytotoxic lectin ricin can be chemically blocked in high yield with reactive ligands prepared by chemical modification of glycopeptides containing triantennary N-linked oligosaccharides

1991 • 85 citations

Cytotoxic activity of an interleukin 6-Pseudomonas exotoxin fusion protein on human myeloma cells.

1988 • 82 citations

Single-chain immunotoxins directed at the human transferrin receptor containing Pseudomonas exotoxin A or diphtheria toxin: anti-TFR(Fv)-PE40 and DT388-anti-TFR(Fv).

1991 • 81 citations

Cellular processing of the interleukin-2 fusion toxin DAB486-IL-2 and efficient delivery of diphtheria fragment A to the cytosol of target cells requires Arg194

1990 • 81 citations

A recombinant single-chain immunotoxin composed of anti-Tac variable regions and a truncated diphtheria toxin.

1990 • 80 citations

Autologous bone marrow transplantation in high-risk remission T-lineage acute lymphoblastic leukemia using immunotoxins plus 4- hydroperoxycyclophosphamide for marrow purging

1990 • 80 citations

The recombinant immunotoxin anti-Tac(Fv)-Pseudomonas exotoxin 40 is cytotoxic toward peripheral blood malignant cells from patients with adult T-cell leukemia.

1990 • 80 citations

Antitumor activity in mice of an immunotoxin made with anti-transferrin receptor and a recombinant form of Pseudomonas exotoxin.

1989 • 76 citations

Cloned fragment of diphtheria toxin linked to T cell-specific antibody identifies regions of B chain active in cell entry.

1986 • 76 citations

Anti-tumor activities of immunotoxins made of monoclonal antibody B3 and various forms of Pseudomonas exotoxin.

1991 • 70 citations

Transforming growth factor alpha-Pseudomonas exotoxin fusion protein prolongs survival of nude mice bearing tumor xenografts.

1990 • 69 citations

A phase I study of T101-ricin A chain immunotoxin in refractory chronic lymphocytic leukemia.

1988 • 69 citations

Antitumor activity of intraperitoneal immunotoxins in a nude mouse model of human malignant mesothelioma.

1987 • 67 citations

Antitumor activity of a transforming growth factor alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE40).

1991 • 66 citations

Pseudomonas exotoxin coupled to a monoclonal antibody against ovarian cancer inhibits the growth of human ovarian cancer cells in a mouse model.

1987 • 64 citations

Epidermal growth factor receptor expression in 72 meningiomas

1990 • 63 citations

Epidermal Growth Factor in the Normal and Neoplastic Kidney and Bladder

1988 • 60 citations

Antitumor activity of an immunotoxin in a nude mouse model of human ovarian cancer.

1987 • 60 citations

Cytotoxicity of interleukin 2-toxin toward lymphocytes from patients with adult T-cell leukemia.

1989 • 56 citations

Cytotoxicity of a recombinant ricin‐A‐chain fusion protein containing a proteolytically‐cleavable spacer sequence

1990 • 54 citations

Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain.

1989 • 54 citations

In vitro endoproteolytic cleavage of castor bean lectin presursors

1985 • 49 citations

Sequential effects of interleukin 2-diphtheria toxin fusion protein on T-cell activation.

1989 • 49 citations

Oncogene‐associated tumor antigens as targets for immunotherapy

1989 • 48 citations

Cytotoxic activity of a recombinant fusion protein between interleukin 4 and Pseudomonas exotoxin.

1989 • 42 citations

Antitumor effects of interleukin 6-Pseudomonas exotoxin chimeric molecules against the human hepatocellular carcinoma, PLC/PRF/5 in mice.

1991 • 36 citations

Humoral immune responses to XMMCO-791-RTA immunotoxin in colorectal cancer patients.

1989 • 35 citations

Cytotoxic activity of chimeric proteins composed of acidic fibroblast growth factor and Pseudomonas exotoxin on a variety of cell types

1991 • 31 citations

Isolation and characterization of Pseudomonas aeruginosa exotoxin A binding glycoprotein from mouse LM cells

1991 • 30 citations

Cytotoxic activity of a recombinant fusion protein between insulin-like growth factor I and Pseudomonas exotoxin.

1991 • 29 citations

Intracellular routing rather than cross-linking or rate of internalization determines the potency of immunotoxins directed against different epitopes of sIgD on murine B cells

1991 • 27 citations

Diphtheria toxin-related alpha-melanocyte-stimulating hormone fusion toxin. Internal in-frame deletion from Thr387 to His485 results in the formation of a highly potent fusion toxin which is resistant to proteolytic degradation

1991 • 25 citations

Cytotoxicity of IL6-PE40 and derivatives on tumor cells expressing a range of interleukin 6 receptor levels.

1990 • 25 citations

IL-2-PE40 prevents the development of tumors in mice injected with IL-2 receptor expressing EL4 transfectant tumor cells.

1990 • 25 citations

IL-2-PE40 is cytotoxic for activated T lymphocytes expressing IL-2 receptors.

1988 • 24 citations

Diphtheria-related peptide hormone gene fusions: A molecular genetic approach to chimeric toxin development

1988 • 20 citations

Pseudomonas exotoxin — Immunotoxins

1988 • 20 citations

The interleukin-2 receptor on malignant cells: A target for diagnosis and therapy

1986 • 17 citations

Treatment of leukemia patients with T101 ricin A chain immunotoxins

1988 • 13 citations

Cited By (0)

Loading...
Recombinant Toxins for Cancer Treatment (1991) – Science | Metascience Observatory Explorer